These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20564276)

  • 41. Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured.
    Messori L; Cubo L; Gabbiani C; Álvarez-Valdés A; Michelucci E; Pieraccini G; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Casini A; Quiroga AG
    Inorg Chem; 2012 Feb; 51(3):1717-26. PubMed ID: 22225466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF; Bodtke A; Bednarski PJ
    Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
    Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E; Barenholz Y; Gibson D; Najajreh Y
    J Med Chem; 2002 Nov; 45(24):5196-204. PubMed ID: 12431047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.
    Wu K; Hu W; Luo Q; Li X; Xiong S; Sadler PJ; Wang F
    J Am Soc Mass Spectrom; 2013 Mar; 24(3):410-20. PubMed ID: 23404464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New steroidal 7-azaindole platinum(II) antitumor complexes.
    Zamora A; Rodríguez V; Cutillas N; Yellol GS; Espinosa A; Samper KG; Capdevila M; Palacios O; Ruiz J
    J Inorg Biochem; 2013 Nov; 128():48-56. PubMed ID: 23932925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential.
    Lana F; Sandra A; Ana K; Radmila J; Biljana D; Siniša R
    Anticancer Agents Med Chem; 2016; 16(12):1628-1639. PubMed ID: 27102278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A potent trans-diimine platinum anticancer complex photoactivated by visible light.
    Farrer NJ; Woods JA; Salassa L; Zhao Y; Robinson KS; Clarkson G; Mackay FS; Sadler PJ
    Angew Chem Int Ed Engl; 2010 Nov; 49(47):8905-8. PubMed ID: 20677309
    [No Abstract]   [Full Text] [Related]  

  • 52. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
    Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
    J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.
    Musumeci D; Platella C; Riccardi C; Merlino A; Marzo T; Massai L; Messori L; Montesarchio D
    Dalton Trans; 2016 May; 45(20):8587-600. PubMed ID: 27126508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
    J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
    Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
    Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
    Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
    Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
    Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
    He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
    Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.